LEXISCAN .08 mg/mL

LEXISCAN .08 mg/mL is a pharmaceutical injection solution containing regadenoson. It is used for specific medical purposes and is manufactured by Astellas Pharma US, Inc. in the USA.

LEXISCAN .08 mg/mL, containing regadenoson, is primarily used for diagnostic purposes in medical imaging. It is often administered intravenously to help evaluate blood flow in the heart. This medication is typically used in controlled clinical settings to assist in the diagnosis of certain cardiovascular conditions. Patients should consult their healthcare provider to understand what is LEXISCAN used for in their specific case.

LEXISCAN .08 mg/mL may cause various effects, including changes in heart rate and blood pressure. Some individuals might experience flushing, headache, or dizziness. These effects are generally temporary and subside quickly. Patients should report any persistent or severe symptoms to their healthcare provider.

LEXISCAN .08 mg/mL should be handled with care and administered by trained medical professionals. It is important to inform your healthcare provider about any allergies or medical conditions before use. The medication should be stored as per the manufacturer's instructions to maintain its efficacy.

LEXISCAN .08 mg/mL may interact with other medications, including those that affect heart rate or blood pressure. It is crucial to disclose all current medications to your healthcare provider to avoid potential interactions. Alcohol and certain supplements might also influence the effects of regadenoson.